Portal vein thrombosis in patients with hepatocellular carcinoma and early cirrhosis-prevalence and risk factors

Portal vein thrombosis in patients with hepatocellular carcinoma and early cirrhosis-prevalence and risk factors

Hepatocellular carcinoma (HCC) is frequently associated with portal vein thrombosis (PVT) with prevalence ranging from 25% to 50%. PVT is associated with poor prognosis, limiting the available therapeutic options for these patients. Our objective was to determine the prevalence and risk factors for...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Ecancermedicalscience 2023, Vol.17, p.1581
Hauptverfasser: Siddiqui, Muhammad Tayyab Ul-Hasan, Fareed, Ghulam, Khan, Muhammad Rizwan, Riaz, Amna, Hamid, Saeed Sadiq
Format: Artikel
Sprache:eng
Schlagworte:
Blood clots
Clinical Study
Comorbidity
Flow velocity
Hepatitis C
Hospitals
Liver cancer
Liver cirrhosis
Liver diseases
Medical prognosis
Meetings
Multivariate analysis
Patients
Population
Regression analysis
Risk factors
Thrombosis
Veins & arteries
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Hepatocellular carcinoma (HCC) is frequently associated with portal vein thrombosis (PVT) with prevalence ranging from 25% to 50%. PVT is associated with poor prognosis, limiting the available therapeutic options for these patients. Our objective was to determine the prevalence and risk factors for PVT in patients with HCC. A retrospective analysis was performed on the prospectively collected data from January 2018 to March 2020. All patients with HCC discussed in our weekly multidisciplinary liver clinic were reviewed. Multivariate analysis was done to identify the independent risk factors for PVT in HCC patients. A -value of
ISSN:1754-6605
1754-6605
DOI:10.3332/ecancer.2023.1581